TSJCI Annual Report 2021

Trinity St James’s Cancer Institute Annual Report 2021 30 6.2 Key Priorities for 2022 • In the education development programme, a new MSc in Oncology online is under development and will roll out in Sept 2023. This fully online programme will offer 4 online certificates in Precision Oncology, Drug Development, Cancer Immunotherapy and Cancer Prevention/Survivorship. Students will have the opportunity to build these certificates to diploma or MSc. level. This will attract the interest of trainees across different disciplines (clinical and scientific) both nationally and internationally. • A wider college project is to create an IT platform system to allow all modules (oncology for TSJCI) to be offered as stand-alone modules that are stackable. • These two projects in development will allow us to deliver more flexible, personalised oncology education offerings across all disciplines in TSJCI. • With philanthropy funding from a donor, two Drechsler postgraduate bursaries in Translational Oncology will be advertised in May 2022 and will encourage medical students who have completed 3rd year an opportunity to do an intercalated MSc. This will allow these trainees to embark on a full time MSc in Oncology (taught modules and oncology research experience). On completion of this MSc, they will re-enter 4th year medicine. These medical students are then very competitive to apply for the academic internship programme. • TSJCI are in the progress of formulating a sub joint education committee between Trinity St James’ Cancer Centre and the Beaumont/RCSI Cancer Centre. This will allow this committee to run joint oncology education events and establish a joint career mentoring committee for trainees across the two OECI accredited cancer centres.